Stockreport

Vor Bio to Participate in Upcoming Investor Conferences

Vor Biopharma Inc.  (VOR) 
PDF BOSTON, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announ [Read more]